Maria F. Alvisi
Milan, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications
Adjuvant systemic therapy in early breast cancer and results of a prospective observational multicenter BRIDE study: patients outcome and adherence to guidelines in cancer clinical practice.
Journal: Frontiers in oncology
Published: September 25, 2024
BRCA1 foci test as a predictive biomarker of olaparib response in ovarian cancer patient-derived xenograft models.
Journal: Frontiers in pharmacology
Published: February 22, 2024
Efficacy and safety of ramucirumab plus carboplatin and paclitaxel in untreated metastatic thymic carcinoma: RELEVENT phase II trial (NCT03921671).
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: November 28, 2023
Correction to: Basal expression of RAD51 foci predicts olaparib response in patient-derived ovarian cancer xenografts.
Journal: British journal of cancer
Published: February 16, 2023
Corrigendum to: Immunological Variables Associated With Clinical and Endoscopic Response to Vedolizumab in Patients With Inflammatory Bowel Diseases.
Journal: Journal of Crohn's & colitis
Published: December 01, 2021
Randomized phase II trial of weekly paclitaxel vs. cediranib-olaparib (continuous or intermittent schedule) in platinum-resistant high-grade epithelial ovarian cancer.
Journal: Gynecologic oncology
Published: November 24, 2021
High-dose ivermectin for early treatment of COVID-19 (COVER study): a randomised, double-blind, multicentre, phase II, dose-finding, proof-of-concept clinical trial.
Journal: International journal of antimicrobial agents
Published: November 09, 2021
Basal expression of RAD51 foci predicts olaparib response in patient-derived ovarian cancer xenografts.
Journal: British journal of cancer
Published: June 07, 2021
Single-arm, open label prospective trial to assess prediction of the role of ERCC1/XPF complex in the response of advanced NSCLC patients to platinum-based chemotherapy.
Journal: ESMO open
Published: October 19, 2020
Last Updated: 09/26/2026